Surgical Innovations Group PLC
LSE:SUN
Surgical Innovations Group PLC
Total Receivables
Surgical Innovations Group PLC
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Surgical Innovations Group PLC
LSE:SUN
|
Total Receivables
£2m
|
CAGR 3-Years
16%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
Smith & Nephew PLC
LSE:SN
|
Total Receivables
$1.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Total Receivables
$209.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
15%
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Total Receivables
$65.2m
|
CAGR 3-Years
33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Total Receivables
£9.1m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
Creo Medical Group PLC
LSE:CREO
|
Total Receivables
£11.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
See Also
What is Surgical Innovations Group PLC's Total Receivables?
Total Receivables
2m
GBP
Based on the financial report for Dec 31, 2023, Surgical Innovations Group PLC's Total Receivables amounts to 2m GBP.
What is Surgical Innovations Group PLC's Total Receivables growth rate?
Total Receivables CAGR 10Y
-6%
Over the last year, the Total Receivables growth was -2%. The average annual Total Receivables growth rates for Surgical Innovations Group PLC have been 16% over the past three years , -7% over the past five years , and -6% over the past ten years .